News

During past eight months, due to the coronavirus pandemic, mediators, lawyers and clients have experienced something once inconceivable: Almost all mediations have been conducted remotely. What have we learned from this experience so far, and how can we improve it?...

In July of 2016, Lisa and Robert Gerbino (hereinafter “Gerbinos”) made an application to the Town of East Hampton Zoning Board of Appeals (“ZBA”) for setback relief to allow an existing patio that was built without a permit to remain 10.2 feet from the southern property line where 20 feet is requ

Governors and public health officials across the country have implemented stringent measures to help contain the spread of COVID-19, such as safer at home orders. As businesses reopen, face coverings remain popular as a preventative measure....

Car accidents happen quickly.  The following is probably a very familiar scenario. The car in the lane beside you loses control. You try to swerve out of the way, but you’re not quick enough. You try to brake at the last second....

Earlier this year, we reported on the New Jersey Assembly’s unanimous (78-0) vote approving Assembly Bill 1263, supplementing New Jersey’s Viatical Settlements Act, N.J.S.A.

The PCAOB released an interim analysis report and two accompanying white papers providing the PCAOB’s perspective on the initial impact of critical audit matter (CAM) requirements and insights learned from stakeholders....

We have seen a significant evolution in data privacy compliance and enforcement.  With the advances in technology, the public has become concerned about the collection, analysis and application of personal data....

The Office of the Comptroller of the Currency (OCC) issued a final rule on October 27 that determines when a national bank or federal savings association (bank) makes a loan and is the “true lender” in the context of a partnership between a bank and a third party, such as a marketplace lender....

In Washington: The Trump administration will pay Eli Lilly $375 million to supply 300,000 doses of its experimental antibody drug to treat COVID-19, the Department of Health and Human Services said Wednesday.

Pages